Xlife Sciences AGXSWX:XLS -11.06%50 Days Inventory is 69.83 as of Dec. 2025, which is 29% above its 10-year median of 54.20. GuruFocus rates XSWX:XLS with a GF Score™ of 50/100 and a GF Value™ of CHF7.30 (Significantly Overvalued). The stock has 13 warning signs investors should review. Among 640 Biotechnology companies, Xlife Sciences AG ranks better than 85.31% on this metric.
The historical rank and industry rank for Xlife Sciences AG's Days Inventory or its related term are showing as below:
XSWX:XLS'
s Days Inventory Range Over the Past 10 Years
Min: 50.77 Med: 54.2 Max: 57.63
Current: 54.89
During the past 8 years, Xlife Sciences AG's highest Days Inventory was 57.63. The lowest was 50.77. And the median was 54.20.
XSWX:XLS's Days Inventory is ranked better than 85.31% of 640
companies
in the Biotechnology industry
Industry Median: 184.145
vs XSWX:XLS: 54.89
Xlife Sciences AG's Days Inventory
increased
from Dec. 2024 (55.12) to Dec. 2025 (69.83).
It might indicate that Xlife Sciences AG's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Xlife Sciences AG's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.61.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Xlife Sciences AG (XSWX:XLS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Xlife Sciences AG's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Xlife Sciences AG's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Xlife Sciences AG Days Inventory Related Terms
Xlife Sciences AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Xlife Sciences AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:XLS vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Xlife Sciences AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xlife Sciences AG Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Xlife Sciences AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xlife Sciences AG (XSWX:XLS) has a Days Inventory of 69.83 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Xlife Sciences AG and its competitors. This is 29% above median its historical median of 54.20. Over the past decade, Xlife Sciences AG's Days Inventory has ranged from 50.77 to 57.63. According to the industry distribution chart, Xlife Sciences AG ranks #94 out of 640 companies in the Biotechnology industry, placing it in the top 14.7%.
Is Xlife Sciences AG's Days Inventory too high?
Xlife Sciences AG's current Days Inventory of 69.83 is 29% above median its 10-year median of 54.20. Over the past 10 years, this metric has ranged from a low of 50.77 to a high of 57.63. The Biotechnology industry median Days Inventory is 184.15. Xlife Sciences AG's value of 69.83 is 62.1% below this industry median. Based on the distribution chart, Xlife Sciences AG ranks #94 out of 640 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Xlife Sciences AG has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Xlife Sciences AG's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xlife Sciences AG ranks #94 out of 640 companies for Days Inventory. This places Xlife Sciences AG in the top 15% of its industry — outperforming the majority of peers. The industry median Days Inventory is 184.15. Xlife Sciences AG's value of 69.83 is 62.1% below this benchmark. Historically, Xlife Sciences AG's own Days Inventory has ranged from 50.77 to 57.63 over the past decade. While the company's 10-year median is 54.20 vs. the industry median of 184.15, Xlife Sciences AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xlife Sciences AG's current Days Inventory of 69.83 is 62.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Xlife Sciences AG and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xlife Sciences AG's current Days Inventory is 69.83, which is 29% above median its own 10-year median of 54.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xlife Sciences AG stock overvalued right now?
Based on GuruFocus' analysis, Xlife Sciences AG (XSWX:XLS) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF7.30, compared to a current price of CHF20.90 — trading 186.3% above its estimated fair value. The current Days Inventory is 69.83, which is 29% above median its 10-year median of 54.20 and 62.1% below the Biotechnology industry median of 184.15. Xlife Sciences AG's overall GF Score™ is 50/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Xlife Sciences AG (XSWX:XLS), the current Days Inventory is 69.83 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xlife Sciences AG (XSWX:XLS) Overvalued in 2026?
Based on GuruFocus' analysis, Xlife Sciences AG stock appears to be overvalued.
The current stock price of CHF20.90 is trading 186.3% above its estimated GF Value™ of CHF7.30.
GuruFocus considers Xlife Sciences AG to be Significantly Overvalued.
Key valuation signals for XSWX:XLS:
Days Inventory: 69.83 (29% above median its 10-year median of 54.20)
GF Value™: CHF7.30 vs. price of CHF20.90 (186.3% above fair value)
Industry Position: 62.1% below the Biotechnology median (#94 of 640)
No single metric tells the full story. See the XSWX:XLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high-unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments, which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial Intelligence/Digital Medicine.
50GF Score
Get the complete analysis for XSWX:XLS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:XLS has been successfully added to your 
